Article

Fecundability among women with type 1 and type 2 diabetes in the Norwegian Mother and Child Cohort Study

Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, P.O. Box 12233, Mail Drop A3-05, Durham, NC 27709, USA.
Diabetologia (Impact Factor: 6.67). 03/2011; 54(3):516-22. DOI: 10.1007/s00125-010-2003-6
Source: PubMed

ABSTRACT

We assessed the effects of type 1 diabetes and type 2 diabetes on fecundability (as manifest by increased time-to-pregnancy [TTP]) in a large cohort of pregnant women.
This study is based on the Norwegian Mother and Child Cohort Study. Members of this large cohort were enrolled early in pregnancy and asked about TTP and other factors. Among the 58,004 women included in the analysis, we identified 221 cases of type 1 diabetes and 88 cases of type 2 diabetes using the Medical Birth Registry of Norway. A logistic analogue of the proportional probability model, a Cox-like discrete-time model, was used to compute fecundability odds ratios (FORs) and 95% CI for type 1 diabetes and type 2 diabetes, adjusted for maternal age and prepregnancy BMI.
Compared with non-diabetic women, the adjusted FOR for women with type 1 diabetes was 0.76 (95% CI 0.64-0.89) and the adjusted FOR for women with type 2 diabetes was 0.64 (95% CI 0.48-0.84). These FORs did not change substantively and remained statistically significant after excluding women with irregular menstrual cycles and accounting for cycle length.
The results from the present study provide evidence of substantially decreased fecundability for women with type 1 and type 2 diabetes, even among those with a normal menstrual cycle.

Download full-text

Full-text

Available from: Rolv Skjaerven, Jan 05, 2016
  • Source
    • "Where there is a medical condition that influences the intrinsic conception rate (e.g. type 1 or type 2 diabetes [39]), this can be taken into account by estimating a distribution for the intrinsic conception rate for people with the condition. It would then be possible to specify how many cycles of non-conception should precede medical intervention for couples in which the condition is present. "
    [Show abstract] [Hide abstract]
    ABSTRACT: An important problem in reproductive medicine is deciding when people who have failed to become pregnant without medical assistance should begin investigation and treatment. This study describes a computational approach to determining what can be deduced about a couple's future chances of pregnancy from the number of menstrual cycles over which they have been trying to conceive. The starting point is that a couple's fertility is inherently uncertain. This uncertainty is modelled as a probability distribution for the chance of conceiving in each menstrual cycle. We have developed a general numerical computational method, which uses Bayes' theorem to generate a posterior distribution for a couple's chance of conceiving in each cycle, conditional on the number of previous cycles of attempted conception. When various metrics of a couple's expected chances of pregnancy were computed as a function of the number of cycles over which they had been trying to conceive, we found good fits to observed data on time to pregnancy for different populations. The commonly-used standard of 12 cycles of non-conception as an indicator of subfertility was found to be reasonably robust, though a larger or smaller number of cycles may be more appropriate depending on the population from which a couple is drawn and the precise subfertility metric which is most relevant, for example the probability of conception in the next cycle or the next 12 cycles. We have also applied our computational method to model the impact of female reproductive ageing. Results indicate that, for women over the age of 35, it may be appropriate to start investigation and treatment more quickly than for younger women. Ignoring reproductive decline during the period of attempted conception added up to two cycles to the computed number of cycles before reaching a metric of subfertility.
    Full-text · Article · Oct 2012 · PLoS ONE
  • Source
    • "Preimplantation human conceptuses are sensitive to insulin and may be directly affected by maternal insulin resistance, and rat models have shown that excess insulin leads to reduced preimplantation. Although findings in rat models cannot be directly applied to humans, they provide information on how insulin resistance may affect fertility (14). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The current study sought to identify macroscopic placental changes associated with clinical conditions in women with or without diabetes and their newborns. The study population consisted of 62 pregnant women clinically diagnosed with diabetes and 62 healthy women (control group). Among the subjects with diabetes, 43 women (69.3%) were diagnosed with gestational diabetes mellitus, 15 had diabetes mellitus I (24.2%), and four had diabetes mellitus II (6.5%). The mean age of the women studied was 28.5 ± 5.71 years, and the mean gestational age of the diabetic women was 38.51 weeks. Of the 62 placentas from diabetic pregnancies, 49 (79%) maternal surfaces and 59 (95.2%) fetal surfaces showed abnormalities, including calcium and fibrin deposits, placental infarction, hematoma, and fibrosis. A statistical association was found between newborn gender and fetal and maternal placental changes (p = 0.002). The mean weight of the newborns studied was 3,287 ± 563 g for women with diabetes mellitus, 3,205 ± 544 g for those with gestational diabetes mellitus, 3,563 ± 696 g forthose with diabetes mellitus II, and 3,095 ± 451 g forthose with diabetes mellitus I. Infarction, hematoma, calcification, and fibrin were found on the maternal and fetal placental surfaces in women with diabetes. Women with gestational diabetes and post-term infants had more calcium deposits on the maternal placental surface as compared to those with type I and type II diabetes.
    Full-text · Article · Oct 2012 · Clinics (São Paulo, Brazil)
  • Source
    • "Prior studies have mainly compared the effect of myomectomy among women who had been referred for fertility concerns, who might have tried other infertility treatments before undergoing leiomyoma removal, or might have more severe leiomyomata; so results would not be expected to be generalizable to this cohort or other women of childbearing age. In addition, we note that the median time to pregnancy observed in our study (two cycles) is similar to that seen in other studies examining time to pregnancy among women who eventually conceive (Gnoth et al., 2003; Baird and Wilcox, 1985; Whitworth et al., 2011). Additionally, it is important to note that leiomyomata size and location were determined following conception. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Previous research suggests the removal of uterine leiomyomata may improve ability to conceive. Most of this previous research was conducted in infertility clinics. We investigated the association between leiomyoma characteristics on time to pregnancy among women enrolled from the general population. We enrolled a cohort study of women in early pregnancy. Participants retrospectively reported their time to conception. Leiomyomata characteristics were determined by first-trimester ultrasound. We used discrete time hazard models to estimate the effects of uterine leiomyomata on time to pregnancy. In this population of 3000 women, 11% (324) with one or more leiomyomata, we found no association between leiomyomata presence, type, location, segment or size on time to pregnancy. These results suggest that leiomyomata have little effect on time to pregnancy in this cohort of women. The study excluded women who had been treated for infertility, and this may have resulted in underestimation of the association. However, differences between our study and previous studies in specialty clinics may be, in part, attributable to differences between our community-recruited population of women and women receiving fertility care, as well as difference in leiomyomata size or type in women having myomectomies to treat infertility.
    Preview · Article · Jul 2012 · Human Reproduction
Show more